At a G-20 Summit session in Rome on Saturday, Prime Minister Narendra Modi stated that India is prepared to produce over 5 billion Covid vaccine doses next year to aid the global fight against the pandemic and that the WHO must approve Indian vaccines as soon as possible. Covaxin from Bharat Biotech and Covishield from AstraZeneca and Oxford University are the two most widely used vaccines in India.
According to the text of his involvement shared by his office, the prime minister also raised the issue of facilitating international travel and discussed the method of bilateral agreements of vaccine certification as a way of accomplishing this in his involvement at the session on “global economy and global health. Foreign Secretary Harsh Vardhan Shringla briefed the media on PM Modi’s activities and said he was pleased with the G20’s decision to propose a 15 percent minimum corporate tax to make the global financial architecture more “just and fair.” He even made sure that businesses pay a specific level of tax in the nations where they operate.
Sringla went on to say that this will be available not only to our citizens but also to the rest of the globe and that it is our contribution to decreasing vaccination disparities, particularly in developing countries. He also emphasized India’s commitment to preserving the global supply chain throughout the pandemic by providing medical supplies to over 150 countries.
Prime Minister Modi spoke about India’s ambitious economic reforms and asked G20 nations to make India an ally in economic recovery and supply chain expansion, emphasizing the importance of resilient global supply networks. He also discussed the “One Earth, One Health” idea concerning the outbreak and ongoing global health challenges, according to Shringla.